Skip to Content

Tag: Glooko

Also Noted

Glooko, Eli Lilly to collaborate on connected insulin pens

May 7, 2021HME News Staff

GOTHENBURG, Sweden – Glooko will partner with Eli Lilly for a strategic digital health collaboration using Eli Lilly’s connected insulin pens, the Tempo Pen and Tempo Smart Button. Through the agreement, the Tempo Smart Button will pair with Glooko’s software to integrate personalized health care data from the Tempo Pen, allowing it to be viewed and analyzed alongside other relevant data from other devices, fitness trackers and food logs. “Lilly is...

Eli Lilly, Glooko, Insulin pen

Read Full Articlered right arrow icon


Crushing it? For the diabetes herd, technology is path forward

April 13, 2021Theresa Flaherty, Managing Editor

I got my first COVID vaccination in early April and immediately slacked my co-workers to share an image of my “Crushing COVD-19” sticker. Along with the obligatory congratulatory emojis, came the obligatory jokes about government chips and tracking. As a person with diabetes, I’m used to tracking. I track my numbers, my insulin doses and my carbs. In turn, my Freestyle Libre sensor tracks me and sends data wirelessly to the Diabetes Center from my iPhone (no more arriving at...

Ascensia Diabetes Care, COVID-19 Vaccine, Diabetes, Glooko

Read Full Articlered right arrow icon

Russ Johannesson

Specialty Providers

Glooko raises stakes on remote monitoring 

April 2, 2021Theresa Flaherty, Managing Editor

PALO ALTO, Calif. – Glooko saw its remote monitoring business take off in 2020 and plans to use recent funding to increase adoption of its platform by diabetes patients and their health care providers.  The company, which provides a software-as-a-service application and accompanying mobile app, will ramp up its marketing, among other efforts, after raising $30 million in Series D funding.  “Remote monitoring is a solution we’ve...

Diabetes, Glooko, Remote Patient Monitoring, Russ Johannesson

Read Full Articlered right arrow icon


In brief: Oxygen adjustment, in-person visits, PromptCare sale, Glooko’s raise 

March 19, 2021HME News Staff

WASHINGTON – CMS has published an adjusted fee schedule for oxygen therapy for April 2021 that no longer includes a percentage reduction to meet the budget neutrality requirement.  The adjustments result in an increase in fee schedule amounts ranging from $6.72 to $8.19 in former competitive bidding areas; $5.17 to $5.43 in other non-rural areas; and $4.14 to $6.82 in non-contiguous and rural areas, according to the VGM Group.  The fee schedule amounts are not retroactive...

Budget Neutrality, face-to-face, Glooko, M&A, Oxygen reimbursement, PromptCare

Read Full Articlered right arrow icon

Specialty Providers

Glooko raises $30M to accelerate growth

March 17, 2021HME News Staff

PALO ALTO, Calif. – Glooko, a provider of remote patient monitoring and chronic care management solutions including diabetes and obesity, has raised a $30 million Series D round of funding.   The company will use proceeds from the funding to accelerate organic growth and strategic initiatives across its product line of digital health solutions, including increasing adoption of is remote patient monitoring platform, widening commercialization of products...

Diabetes, Glooko, Remote monitoring

Read Full Articlered right arrow icon

Also Noted

Glooko receives ISO certification

December 11, 2019HME News Staff

MOUNTAIN VIEW, Calif. - Glooko has received joint ISO 13485 certification from Intertek Testing Services NA Ltd. for both its Mountain View, Calif., and Gothenburg, Sweden, sites. This certification demonstrates the company's commitment to establishing a compliant quality management system that meets customer, safety and regulatory requirements for medical devices. “Our certification to ISO 13485 is an important milestone that confirms our quality management system has met internationally-recognized...

Diabetes Supplies, Glooko

Read Full Articlered right arrow icon

Also Noted

People news: RESNA, Glooko

July 17, 2019HME News Staff

Julie Piriano will be chair of RESNA's Professional Specialty Board effective Aug. 1. Piriano, director of rehab industry affairs at Pride Mobility, is highly active on legislative and regulatory issues for the complex rehab industry and has been a member of RESNA for more than 20 yearsStephen Lien has been named CFO at Glooko, a diabetes data management company. Lien has extensive experience in senior leadership roles, most recently as CFO of PipelineRx, a healthcare SaaS technology company offering...

CRT, Diabetes, Glooko, Julie Piriano, RESNA, Stephen Lien

Read Full Articlered right arrow icon

Specialty Providers

Glooko, T1D Exchange partner on data

July 1, 2019Theresa Flaherty, Managing Editor

MOUNTAIN VIEW, Calif. — Connecting lifestyle data from personal devices with clinical data from electronic health records will offer a fuller understanding of patients with Type 1 diabetes and, ultimately, lead to better treatment, says Russ Johannesson, CEO of Glooko.“We think this is really going to be valuable in enhancing their effort and improving research,” he said. “The ability to see all of this data in context is relatively new.”Glooko recently partnered with...

Glooko, Russ Johannesson, T1D Exchange, Type 1 diabetes

Read Full Articlered right arrow icon

Also Noted

Glooko partners with T1D Exchange

June 5, 2019HME News Staff

MOUNTAIN VIEW, Calif., and BOSTON - Glooko's diabetes management platform will be used to incorporate data from devices like insulin pumps, CGMs and glucometers into the T1D Exchange Quality Improvement Collaborative as part of a new partnership. The QIC researches how more than 30,000 individuals and their healthcare providers treat, measure and manage their diabetes, and identifies which practices make a difference in improving healthcare outcomes and change the course of treatment and management...

Diabetes, Glooko, T1D Exchange

Read Full Articlered right arrow icon

Also Noted

Glooko receives FDA clearance, hires CEO

January 18, 2013HME News Staff

PALO ALTO, Calif. - In a busy week, Glooko saw one of its diabetes monitoring apps get FDA clearance, and announced the hiring of a new CEO, according to news reports. The Glooko's Logbook Charts, an app that enables users to visually analyze glucose data from their smartphones, received FDA approval, allowing the company to expand distribution and sell the product over the counter, as well as directly to consumers, in the U.S. Prior to the clearance, the product was available only in Europe....

Diabetes Supplies, Glooko, Rick Altinger

Read Full Articlered right arrow icon